Contineum Therapeutics, Inc. Class A Common Stock (CTNM)
USD 13.75
(-2.2%)
USD 13.75
(-2.2%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | 19.34 Million | -20.12 Million | -26.26 Million |
| Net Income | 22.72 Million | -24.25 Million | -29 Million |
| Depreciation & Amortization | 195 Thousand | 329 Thousand | 325 Thousand |
| Deferred income taxes | - | - | - |
| Stock-based compensation | 2.21 Million | 1.92 Million | 1.74 Million |
| Change in working capital | -1.02 Million | -1.26 Million | 108 Thousand |
| Other non-cash items | -2.15 Million | 5.95 Million | 164 Thousand |
| Investing Cash Flow | -65.56 Million | 22.29 Million | -64.96 Million |
| Investments in PPE | -414 Thousand | -118 Thousand | -168 Thousand |
| Acquisitions | - | - | - |
| Investment purchases | -141.86 Million | -64.69 Million | -66.77 Million |
| Sales/Maturities of investments | 76.71 Million | 87.11 Million | 1.97 Million |
| Other Investing Activities | -65.15 Million | 22.41 Million | -64.8 Million |
| Financing Cash Flow | 56.17 Million | -1.23 Million | 79.83 Million |
| Debt repayment | -3.75 Million | -1.25 Million | - |
| Dividends payments | - | - | - |
| Common Stock Repurchased | -28 Thousand | -4000.00 | - |
| Common Stock Issuance | 59.95 Million | 15 Thousand | - |
| Other Financing Activities | -343 Thousand | 15 Thousand | 79.83 Million |
| Accounts receivables | - | - | - |
| Accounts payables | - | -230 Thousand | -110 Thousand |
| Inventory | - | - | - |
| Other working capital | -1.02 Million | -1.03 Million | 218 Thousand |
| Cash at beginning of period | 5.56 Million | 4.63 Million | 16.02 Million |
| Cash at end of period | 15.52 Million | 5.56 Million | 4.63 Million |
| Capital Expenditure | -414 Thousand | -118 Thousand | -168 Thousand |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | 9.95 Million | 939 Thousand | -11.39 Million |
| Free Cash Flow | 18.93 Million | -20.23 Million | -26.43 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9 Million | -8.41 Million | 22.72 Million | -7.76 Million | -6.25 Million | 41.56 Million |
| Depreciation & Amortization | 60 Thousand | 61 Thousand | 195 Thousand | 37 Thousand | 43 Thousand | 42 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.49 Million | 768 Thousand | 2.21 Million | 759 Thousand | 477 Thousand | 489 Thousand |
| Change in working capital | -209 Thousand | 275 Thousand | -1.02 Million | -2.79 Million | 1.11 Million | 1.66 Million |
| Other non-cash items | 749 Thousand | 158 Thousand | -2.15 Million | 263 Thousand | 236 Thousand | -2.19 Million |
| Investing Cash Flow | -38.89 Million | 8.73 Million | -65.56 Million | 9.03 Million | -39.49 Million | -44.45 Million |
| Investments in PPE | -119 Thousand | -147 Thousand | -414 Thousand | -309 Thousand | -22 Thousand | -31 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -69 Million | -30.64 Million | -141.86 Million | -21.99 Million | -52.07 Million | -58.57 Million |
| Sales/Maturities of investments | 30.22 Million | 39.51 Million | 76.71 Million | 31.33 Million | 12.6 Million | 14.15 Million |
| Other Investing Activities | - | 8.87 Million | -65.15 Million | 9.33 Million | - | - |
| Financing Cash Flow | 108.22 Million | 122 Thousand | 56.17 Million | -321 Thousand | 10.32 Million | 46.78 Million |
| Debt repayment | - | - | -3.75 Million | - | - | -3.12 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -28 Thousand | 1000.00 | - | - |
| Common Stock Issuance | 108.22 Million | 122 Thousand | 59.95 Million | - | - | 49.91 Million |
| Other Financing Activities | 108.36 Million | -140 Thousand | -343 Thousand | -322 Thousand | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 170 Thousand | -70 Thousand | - | -625 Thousand | 656 Thousand | -313 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -379 Thousand | 345 Thousand | -1.02 Million | -2.16 Million | - | 1.97 Million |
| Cash at beginning of period | 16.26 Million | 15.52 Million | 5.56 Million | 17.52 Million | 52.06 Million | 9.06 Million |
| Cash at end of period | 77.23 Million | 16.26 Million | 15.52 Million | 15.52 Million | 17.52 Million | 52.06 Million |
| Capital Expenditure | -119 Thousand | -147 Thousand | -414 Thousand | -309 Thousand | -22 Thousand | -31 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 60.96 Million | 738 Thousand | 9.95 Million | -1.99 Million | -34.54 Million | 43 Million |
| Free Cash Flow | -8.47 Million | -8.26 Million | 18.93 Million | -11.01 Million | -5.39 Million | 40.64 Million |
7030
RAM
TRV
5753
0HJO
BKEAY